May 1, 2026
Eliaz Therapeutics
Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body
- Round
- Equity Crowdfunding
- Amount raised
- $642K
- Lead investor
- National Institutes of Health
- Industry
- Biotechnology
- Headquarters
- Santa Rosa, United States
- Employees
- 1-10
- Website
- eliaztherapeutics.com
- View profile →
Source: Crunchbase snapshot 2026-05-15